Trinity Biotech was founded in 1992 and listed on the NASDAQ market shortly after its formation. Through a combination of sustained, organic growth and an acquisition-led strategy, the company has assembled an impressive product portfolio and achieved the highest standards of excellence in developing, manufacturing and marketing diagnostic products.
Today Trinity Biotech is listed on the NASDAQ Global Select Market, and has approximately 21 million American Depository Shares.
The Company, which has its headquarters in Bray, Ireland, employs in excess of 350 people worldwide and markets its portfolio of over 400 products to customers in over 75 countries around the world.
Trinity Biotech’s growth to date has involved the following:
Acquired Disease Detection International, Irvine, California, USA.
Launched Uni-Gold™ HIV and One-step test.
Acquired Clark Laboratories, Jamestown, New York, USA.
Acquired Centocor, Cambridge, UK.
Opened 50,000 sq. ft. manufacturing facility in Bray, Ireland.
Acquired Hormone & Drugs of Abuse from Diatech, Boston, USA.
Acquired Macra® Lp(a) from Strategic Diagnostics Inc., USA.
Acquired HIV product line from Cambridge Diagnostics, USA.
Acquired MicroTrak® product line from Dade Behring, USA.
Acquired MarDx® Diagnostics, Inc., Carlsbad, California, USA.
Acquired assets and goodwill of Bartels Inc., Oregon, USA.
Establishment of Trinity Biotech German sales and marketing subsidiary
Acquired Biopool, Ventura, California, USA.
Acquired coagulation division of Sigma Diagnostics, USA.
Establishment of Trinity Biotech UK sales & marketing subsidiary.
Acquired Specialty Clinical Chemistry, Sigma Diagnostics, USA.
FDA clearance for Uni-Gold™ Recombigen® HIV test.
Acquired Adaltis US, Inc.
Acquires Fitzgerald Industries International, Mass, USA.
Received US CLIA Waiver for Uni-Gold™ Recombigen® HIV Test.
Acquired Research Diagnostics Inc., Flanders, New Jersey, USA.
Acquired Primus Corporation of Kansas City, Missouri, USA.
Acquired coagulation division of bioMerieux, Lyon, France.
Acquisition by Stago of the Trinity Biotech coagulation division.